Want to join the conversation?
$EMR 3Q15 PR: Net sales were $5,503MM, down 13% vs. $6,312MM in 3Q14. Underlying sales were down 5% excluding unfavorable currency translation of 5% and an impact from divestitures of 3%. Net earnings were $564MM or $0.84 per diluted share vs. $728MM or $1.03 per diluted share in 3Q14.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.